دورية أكاديمية

P1.16-26 Safety of SABR (Stereotactic Ablative Body Radiotherapy) for Central Non-Small Cell Lung Cancers (cNSCLC) with 50 Gray in 5 Fractions (50Gy/5f)

التفاصيل البيبلوغرافية
العنوان: P1.16-26 Safety of SABR (Stereotactic Ablative Body Radiotherapy) for Central Non-Small Cell Lung Cancers (cNSCLC) with 50 Gray in 5 Fractions (50Gy/5f)
المؤلفون: Rulach, R., Hicks, J., Lumsden, G., Mckay, S., Maclaren, V., Macphee, J., Moore, K., Omand, M., Sproule, M., Currie, S., Aitken, A., Ferguson, R., Houston, P., Valentine, R., Harrow, S.
المصدر: In Journal of Thoracic Oncology October 2018 13(10) Supplement:S637-S637
قاعدة البيانات: ScienceDirect
الوصف
تدمد:15560864
DOI:10.1016/j.jtho.2018.08.995